Description
April 3, 2026
Webinar: Practice Staffing Solutions Using Locum Tenens Pathologists
CAPcast: Head and Neck Cancer Awareness Month
Hosted on Ausha. See ausha.co/privacy-policy for more information.
Transcription
- Nancy Johnson
CMS starts a long goodbye to fax machines and snail mail. Learn what's new on medical imaging interoperability and more on head and neck cancer protocols. These stories and more coming up next. This is Path News Network Daily Edition from the College of American Pathologists. I'm Nancy Johnson. It's Friday, April 3rd. It's a milestone years in the making. The Centers for Medicare and Medicaid Services is officially phasing out fax and snail mail for claims. CMS has finalized its national standards for electronic claims, attachments, and signatures when sending information to health plans. The new rule includes medical records, imaging, and laboratory results. The new standards do not affect clinical workflow. It's not quite the end for fax machines. The rule is effective on May 19th, but you have two years to make the shift. Compliance is required by May 19th of 2028. The CAP is co-sponsoring a free webinar next week on medical image interoperability. The Digital Pathology Association and the Society for Imaging Informatics in Medicine are also sponsors. The session will focus on the organization's recent you DICOM Toolkit Survey and what it reveals about the current standards in digital pathology. DICOM is the Digital Imaging and Communications in Medicine Standard, which applies to the transmission of medical records between different institutions and practices. Kevin Schap, the CAP's Director of Clinical Informatics, Digital Pathology, and Data Science, will be one of the presenters. The webinar will be held April 8th at 11 a.m. Eastern Time. There's still time to register for another upcoming CAP webinar, this one focusing on locum tenens pathologists. The field faces persistent staffing shortages and temporary pathologists can provide coverage during surges in cases, yet they remain an underutilized resource. The webinar will provide insights from practicing locum tenens pathologists, a staffing professional, and a practice executive. They'll discuss the pros and cons of these arrangements and provide practical tips for success. The webinar will be held April 14th from 1 to 2 p.m. Central Time. To sign up, go to cap.org slash calendar slash webinars. And finally, April is Head and Neck Cancer Awareness Month. And as we reported yesterday, the CAP's recent protocol updates you included a major restructuring of head and neck cancer reporting. Today, a deeper dive. The new CapCast podcast features a panel of expert pathologists discussing what the first quarter protocols mean for head and neck cancer diagnosis and treatment. Dr. Raja Seethala, a head and neck and endocrine pathologist at the University of Pittsburgh and a member of the CAP Cancer Committee, explained why protocol updates were needed.
- Dr. Raja Seethala
With the exception of HPV testing, back initially during the first iteration of the biomarker protocol, biomarker testing for head and neck cancer was initially largely restricted to kind of diagnostic purposes and classification. In the past few years, this role did take off. There are numbers of defining supportive molecular alterations. for several sites, including salivary gland, sinus nasal tract, all across the head and neck, and this has expanded almost exponentially.
- Nancy Johnson
On the podcast, the panelists encouraged laboratories and practices to take on the challenge of adopting and understanding the new biomarkers and protocols. Dr. Nicole Cipriani of the University of Chicago, also a member of the CAP Cancer Committee, said,
- Dr. Nicole Cipriani
Pathologists are very important in clinical care, and I would encourage you to actively take a role in utilizing and interpreting biomarkers for the clinical teams. Whether or not your lab performs them or not, you are integral in assisting with that in patient care.
- Nancy Johnson
And that does it for us today. For more information on today's stories, check the show notes. And watch your email inbox for more news like this. in the CAP's Advocacy Newsletter every Tuesday, and our Weekly Edition Newsletter on Thursdays. We'll be back Monday at 5 a.m. Eastern for another episode of The Daily Edition. I'm Nancy Johnson. Have a great weekend.
Description
April 3, 2026
Webinar: Practice Staffing Solutions Using Locum Tenens Pathologists
CAPcast: Head and Neck Cancer Awareness Month
Hosted on Ausha. See ausha.co/privacy-policy for more information.
Transcription
- Nancy Johnson
CMS starts a long goodbye to fax machines and snail mail. Learn what's new on medical imaging interoperability and more on head and neck cancer protocols. These stories and more coming up next. This is Path News Network Daily Edition from the College of American Pathologists. I'm Nancy Johnson. It's Friday, April 3rd. It's a milestone years in the making. The Centers for Medicare and Medicaid Services is officially phasing out fax and snail mail for claims. CMS has finalized its national standards for electronic claims, attachments, and signatures when sending information to health plans. The new rule includes medical records, imaging, and laboratory results. The new standards do not affect clinical workflow. It's not quite the end for fax machines. The rule is effective on May 19th, but you have two years to make the shift. Compliance is required by May 19th of 2028. The CAP is co-sponsoring a free webinar next week on medical image interoperability. The Digital Pathology Association and the Society for Imaging Informatics in Medicine are also sponsors. The session will focus on the organization's recent you DICOM Toolkit Survey and what it reveals about the current standards in digital pathology. DICOM is the Digital Imaging and Communications in Medicine Standard, which applies to the transmission of medical records between different institutions and practices. Kevin Schap, the CAP's Director of Clinical Informatics, Digital Pathology, and Data Science, will be one of the presenters. The webinar will be held April 8th at 11 a.m. Eastern Time. There's still time to register for another upcoming CAP webinar, this one focusing on locum tenens pathologists. The field faces persistent staffing shortages and temporary pathologists can provide coverage during surges in cases, yet they remain an underutilized resource. The webinar will provide insights from practicing locum tenens pathologists, a staffing professional, and a practice executive. They'll discuss the pros and cons of these arrangements and provide practical tips for success. The webinar will be held April 14th from 1 to 2 p.m. Central Time. To sign up, go to cap.org slash calendar slash webinars. And finally, April is Head and Neck Cancer Awareness Month. And as we reported yesterday, the CAP's recent protocol updates you included a major restructuring of head and neck cancer reporting. Today, a deeper dive. The new CapCast podcast features a panel of expert pathologists discussing what the first quarter protocols mean for head and neck cancer diagnosis and treatment. Dr. Raja Seethala, a head and neck and endocrine pathologist at the University of Pittsburgh and a member of the CAP Cancer Committee, explained why protocol updates were needed.
- Dr. Raja Seethala
With the exception of HPV testing, back initially during the first iteration of the biomarker protocol, biomarker testing for head and neck cancer was initially largely restricted to kind of diagnostic purposes and classification. In the past few years, this role did take off. There are numbers of defining supportive molecular alterations. for several sites, including salivary gland, sinus nasal tract, all across the head and neck, and this has expanded almost exponentially.
- Nancy Johnson
On the podcast, the panelists encouraged laboratories and practices to take on the challenge of adopting and understanding the new biomarkers and protocols. Dr. Nicole Cipriani of the University of Chicago, also a member of the CAP Cancer Committee, said,
- Dr. Nicole Cipriani
Pathologists are very important in clinical care, and I would encourage you to actively take a role in utilizing and interpreting biomarkers for the clinical teams. Whether or not your lab performs them or not, you are integral in assisting with that in patient care.
- Nancy Johnson
And that does it for us today. For more information on today's stories, check the show notes. And watch your email inbox for more news like this. in the CAP's Advocacy Newsletter every Tuesday, and our Weekly Edition Newsletter on Thursdays. We'll be back Monday at 5 a.m. Eastern for another episode of The Daily Edition. I'm Nancy Johnson. Have a great weekend.
Share
Embed
You may also like